TCON - Tracon Pharmaceuticals, Inc.
Previous close
1.43
1.430 100.000%
Share volume: 0
Last Updated: Thu 27 Jun 2024 08:08:42 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
22%
Profitability
25%
Dept financing
19%
Liquidity
39%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-59.92%
Return on assets
-18.05%
Return on sales
0%
Return on invested capital
54.44%
Total debt ratio
54.96%
Debt ratio change over timeo
-0.32%
Current Ratio
3.05%
Quick Ratio
0%
Cash Position Ratio
2.45%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-141.85%
Return on assets
-24.3%
Return on sales
0%
Return on invested capital
45.51%
Total debt ratio
82.31%
Debt ratio change over timeo
0.88%
Current Ratio
1.59%
Quick Ratio
0%
Cash Position Ratio
1.51%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-148.22%
Return on assets
-27.57%
Return on sales
0%
Return on invested capital
52.11%
Total debt ratio
80.81%
Debt ratio change over time
0.61%
Current Ratio
1.62%
Quick Ratio
0%
Cash Position Ratio
1.57%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-199.04%
Return on assets
-121.88%
Return on sales
0%
Return on invested capital
-39.99%
Total debt ratio
-32.13%
Debt ratio change over time
-0.32%
Current Ratio
2.22%
Quick Ratio
0%
Cash Position Ratio
1.61%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TCON | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -59.92% | -3.05% | 11.55% | 6.27% |
| Return on assets | -18.05% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 54.44% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 38% | 71% | 64% |
| Total debt ratio | 54.96% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.32% | 6.09% | 6.03% | 1.53% |
| Dept financing | 14% | 50% | 43% | 14% |
| Current Ratio | 1.59% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.51% | 1.48% | 0.76% | 1.49% |
| Liquididy | 46% | 28% | 56% | 61% |
| Short-term ratios | TCON | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -141.85% | -25.62% | 17.94% | 7.14% |
| Return on assets | -24.3% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 45.51% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 43% | 73% | 67% |
| Total debt ratio | 82.31% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | 0.88% | -23.44% | 9.66% | 0.6% |
| Dept financing | 22% | 25% | 45% | 8% |
| Current Ratio | 1.59% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.51% | 1.48% | 0.76% | 1.49% |
| Liquididy | 36% | 56% | 42% | 75% |